Literature DB >> 10397

Meso-dimercaptosuccinic acid a chelating agent for the treatment of mercury and lead poisoning.

E Friedheim, C Crovi, C H Wakker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 10397     DOI： 10.1111/j.2042-7158.1976.tb02843.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  6 in total

1.  Therapeutic efficacy of dimercaptosuccinic acid and thiamine/ascorbic acid on lead intoxication in rats.

Authors:  S K Tandon; S J Flora
Journal:  Bull Environ Contam Toxicol       Date:  1989-11       Impact factor: 2.151

2.  Retention of lead in the rat.

Authors:  J Bankowska; C Hine
Journal:  Arch Environ Contam Toxicol       Date:  1985-09       Impact factor: 2.804

3.  2,3-Dimercaptosuccinic acid in human arsenic poisoning.

Authors:  K Lenz; K Hruby; W Druml; A Eder; A Gaszner; G Kleinberger; M Pichler; M Weiser
Journal:  Arch Toxicol       Date:  1981-06       Impact factor: 5.153

4.  An oral treatment for lead toxicity.

Authors:  P S Thomas; C Ashton
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

Review 5.  The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning.

Authors:  D E Glotzer
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

6.  The effect of heavy metal chelators on the renal accumulation of platinum after cis-dichlorodiammineplatinum II administration to the rat.

Authors:  J Graziano; B Jones; P Pisciotto
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.